Prophylaxis: the next haemophilia treatment
- PMID: 1640188
- DOI: 10.1111/j.1365-2796.1992.tb00543.x
Prophylaxis: the next haemophilia treatment
Comment on
-
Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.J Intern Med. 1992 Jul;232(1):25-32. doi: 10.1111/j.1365-2796.1992.tb00546.x. J Intern Med. 1992. PMID: 1640190
Similar articles
-
[A protocol for the orthopaedic prophylaxis in the rehabilitation of haemarthrosis in haemophilia A ].Sangre (Barc). 1982;27(2):156-64. Sangre (Barc). 1982. PMID: 6812226 Spanish. No abstract available.
-
Radiologic evaluation of prophylaxis in severe haemophilia.Acta Paediatr Scand. 1981 Jul;70(4):565-70. doi: 10.1111/j.1651-2227.1981.tb05741.x. Acta Paediatr Scand. 1981. PMID: 6797235
-
Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S3-5. Blood Coagul Fibrinolysis. 1997. PMID: 9351528 Review.
-
Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.Thromb Haemost. 2008 May;99(5):965; author reply 966-8. doi: 10.1160/TH08-02-0097. Thromb Haemost. 2008. PMID: 18449430 No abstract available.
-
[Status of joint and intracranial bleeding of moderate and severe hemophilia in children under on-demand therapy].Zhonghua Er Ke Za Zhi. 2012 Aug;50(8):636-8. Zhonghua Er Ke Za Zhi. 2012. PMID: 23158747 Review. Chinese. No abstract available.
Cited by
-
Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A.J Blood Med. 2016 Sep 12;7:187-198. doi: 10.2147/JBM.S80814. eCollection 2016. J Blood Med. 2016. PMID: 27695377 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical